Cell Source Stock Market Value

CLCS Stock  USD 0.50  0.02  4.17%   
Cell Source's market value is the price at which a share of Cell Source trades on a public exchange. It measures the collective expectations of Cell Source investors about its performance. Cell Source is selling for under 0.5 as of the 22nd of December 2024; that is 4.17 percent increase since the beginning of the trading day. The stock's lowest day price was 0.5.
With this module, you can estimate the performance of a buy and hold strategy of Cell Source and determine expected loss or profit from investing in Cell Source over a given investment horizon. Check out Cell Source Correlation, Cell Source Volatility and Cell Source Alpha and Beta module to complement your research on Cell Source.
Symbol

Please note, there is a significant difference between Cell Source's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cell Source is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cell Source's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cell Source 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cell Source's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cell Source.
0.00
11/22/2024
No Change 0.00  0.0 
In 30 days
12/22/2024
0.00
If you would invest  0.00  in Cell Source on November 22, 2024 and sell it all today you would earn a total of 0.00 from holding Cell Source or generate 0.0% return on investment in Cell Source over 30 days. Cell Source is related to or competes with Opthea, Molecular Partners, Edgewise Therapeutics, Iteos Therapeutics, and Antibe Therapeutics. Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance More

Cell Source Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cell Source's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cell Source upside and downside potential and time the market with a certain degree of confidence.

Cell Source Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cell Source's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cell Source's standard deviation. In reality, there are many statistical measures that can use Cell Source historical prices to predict the future Cell Source's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cell Source's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.5017.22
Details
Intrinsic
Valuation
LowRealHigh
0.020.4217.14
Details
Naive
Forecast
LowNextHigh
0.010.3817.09
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.410.580.75
Details

Cell Source Backtested Returns

Cell Source is out of control given 3 months investment horizon. Cell Source secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. We were able to break down twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.82% are justified by taking the suggested risk. Use Cell Source Risk Adjusted Performance of 0.0843, downside deviation of 15.55, and Mean Deviation of 10.0 to evaluate company specific risk that cannot be diversified away. Cell Source holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.48, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cell Source are expected to decrease at a much lower rate. During the bear market, Cell Source is likely to outperform the market. Use Cell Source sortino ratio and the relationship between the downside variance and period momentum indicator , to analyze future returns on Cell Source.

Auto-correlation

    
  -0.77  

Almost perfect reverse predictability

Cell Source has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Cell Source time series from 22nd of November 2024 to 7th of December 2024 and 7th of December 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cell Source price movement. The serial correlation of -0.77 indicates that around 77.0% of current Cell Source price fluctuation can be explain by its past prices.
Correlation Coefficient-0.77
Spearman Rank Test-0.64
Residual Average0.0
Price Variance0.01

Cell Source lagged returns against current returns

Autocorrelation, which is Cell Source otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cell Source's otc stock expected returns. We can calculate the autocorrelation of Cell Source returns to help us make a trade decision. For example, suppose you find that Cell Source has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Cell Source regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cell Source otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cell Source otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cell Source otc stock over time.
   Current vs Lagged Prices   
       Timeline  

Cell Source Lagged Returns

When evaluating Cell Source's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cell Source otc stock have on its future price. Cell Source autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cell Source autocorrelation shows the relationship between Cell Source otc stock current value and its past values and can show if there is a momentum factor associated with investing in Cell Source.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cell OTC Stock Analysis

When running Cell Source's price analysis, check to measure Cell Source's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Source is operating at the current time. Most of Cell Source's value examination focuses on studying past and present price action to predict the probability of Cell Source's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Source's price. Additionally, you may evaluate how the addition of Cell Source to your portfolios can decrease your overall portfolio volatility.